We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 15, 2020

A Prospective, Multicenter, Noninterventional Study Assessing Palbociclib in HR+ Advanced Breast Cancer

Future Oncology (London, England)

 

Additional Info

Future Oncology (London, England)
POLARIS: A Prospective, Multicenter, Noninterventional Study Assessing Palbociclib in Hormone Receptor-Positive Advanced Breast Cancer
Future Oncol 2020 Aug 13;[EPub Ahead of Print], D Tripathy, JL Blum, GB Rocque, A Bardia, MS Karuturi, JC Cappelleri, Y Liu, Z Zhang, KL Davis, Y Wang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading